Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

Immune-related manifestations are increasingly recognized conditions in patients with
COVID-19, with around 3,000 cases reported worldwide comprising more than 70 different …

Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with
autoimmune and rheumatic manifestations have been reported. Despite the available …

Since previous evidence has demonstrated that red blood cell distribution width (RDW) may
be a useful prognostic parameter in many critical illnesses and infectious diseases, we …

Invasive mould disease (IMD) might affect up to a third of critically ill patients with COVID-19.
COVID-19-associated pulmonary aspergillosis (CAPA) is typically diagnosed on the basis of …

Summary Although coronavirus disease 2019 (COVID-19) is transmitted via respiratory
droplets, there are multiple gastrointestinal and hepatic manifestations of the disease …

(1) Background: coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been linked to hematological dysfunctions, but …

The use of autopsies in medicine has been declining. The COVID-19 pandemic has
documented and rejuvenated the importance of autopsies as a tool of modern medicine. In …

Context.—This study represents the largest compilation to date of clinical and postmortem
data from decedents with coronavirus disease 2019 (COVID-19). It will augment previously …

Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic
hyperinflammatory syndromes with a common terminal pathway triggered by different …